$TTOO Is T2 Biosystems (TTOO) a possible acquisition target? Tim Rolle October 12, 2020 Featured, Biotech Stocks moneymidnight.com/2020/10/i... T2 holds over 70 patents, which include the fundamental technology behind its instrument. The latest one, granted just a couple months ago, “NMR methods for monitoring blood clot formation” indicates possible future uses for the T2 platform to diagnose blood clots. Beyond T2, I cannot find any other commercialized applications of miniature magnetic resonance for diagnostics at this level. Shares of T2 Biosystems (TTOO) appear to be a very good investment option, the Money Midnight Indicator is expecting its price to increase considerably in the next several years.